Alnylam Pharmaceuticals Extends HQ Lease at 300 Third St in Cambridge, MA

Alnylam Pharmaceuticals, Inc. has exercised its option to extend its corporate headquarters lease at 300 Third St in Cambridge, Mass for an additional five years, through September 30, 2021.

The Company leases a total of approximately 129,000 square feet of office and laboratory space at the building under a lease previously set to expire in September 2016.

The company has leased office and laboratory space at 300 Third Street since signing a lease with landlord ARE-MA Region No. 28, LLC on September 26, 2003. Through various amendments to that lease, the Company has one more option to extend its lease, as amended, for one additional five-year term.

300 Third Street in Cambridge, MA is in close proximity to the Red Line (Kendall) and the Green line (Lechmere) MBTA Stations and the EZ Ride Shuttle Bus. Tenants are surrounded by neighborhood amenities including shops, cafes hotels and numerous restaurants. Neighboring institutions and corporations include MIT, Microsoft, Sanofi, Genzyme, google, Amgen, Biogen, Broad Institute, Nokia, and Whitehead Institute.